Loading clinical trials...
Loading clinical trials...
The aim of the study is to evaluate the safety, feasibility, clinical and biological efficacy, and predictors of efficacy of an intervention consisting of repetitive transcranial magnetic stimulation ...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Università degli Studi di Brescia
NCT04715399 · Frontotemporal Degeneration(FTD), Primary Progressive Aphasia(PPA), and more
NCT07235111 · Alzheimer Disease, FTD, and more
NCT06891716 · Frontotemporal Dementia (FTD), Amyotrophic Lateral Sclerosis (ALS), and more
NCT06803784 · Parkinson Disease, Amyotrophic Lateral Sclerosis (ALS), and more
NCT06051123 · ALSFTD
IRCCS Istituto Centro San Giovanni Di Dio - Fatebenefratelli Brescia
Brescia, Italy
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions